tiprankstipranks
CareCloud (DE:MTB0)
FRANKFURT:MTB0

CareCloud (MTB0) Price & Analysis

0 Followers

MTB0 Stock Chart & Stats

€1.94
>-€0.01(-0.22%)
At close: 4:00 PM EDT
€1.94
>-€0.01(-0.22%)

Bulls Say, Bears Say

Bulls Say
Revenue Growth And Recurring MixStrong recent revenue growth combined with a higher recurring mix improves predictability and customer retention economics. Recurring technology-enabled revenue can support steadier cash generation, deepen platform adoption, and provide a durable base for cross-selling additional software and services.
Profitability And Cash GenerationThe sustained GAAP profitability streak and positive free cash flow indicate that CareCloud is converting its operating model into internally generated funding. This supports continued product investment, reduces reliance on external capital, and provides resilience as the company scales its offerings.
AI And Compliance ExpansionEntry into compliance and audit defense broadens CareCloud’s addressable workflow opportunity beyond core practice management and RCM. Combining acquired expertise with AI-enabled SaaS could create new recurring revenue, strengthen provider relationships, and increase cross-sell potential over time.
Bears Say
Balance-sheet VolatilityAlthough current leverage is described as manageable, rising debt and substantially lower equity reduce financial cushion and increase sensitivity to operating setbacks. The history of unstable capital structure and weak 2023 returns could constrain flexibility if investments or integration plans take longer to pay off.
Near-term Margin And Earnings PressureCareCloud is deliberately increasing investment, but the resulting R&D, integration, amortization, and interest costs are currently reducing reported earnings and adjusted profitability. If these investments do not produce sufficient scale, margin recovery may be slower and cash available for other priorities could remain pressured.
Execution And Integration DependenceThe reaffirmed outlook requires a materially stronger second half and successful execution across integrations, customer activity, and new product launches. Delays in Medsphere remediation, AI deployment, compliance commercialization, or expense control could defer expected scale benefits and weaken near-term results.

CareCloud News

MTB0 FAQ

What was CareCloud’s price range in the past 12 months?
CareCloud lowest stock price was €1.68 and its highest was €3.20 in the past 12 months.
    What is CareCloud’s market cap?
    CareCloud’s market cap is €81.60M.
      When is CareCloud’s upcoming earnings report date?
      CareCloud’s upcoming earnings report date is Oct 29, 2026 which is in 52 days.
        How were CareCloud’s earnings last quarter?
        CareCloud released its earnings results on Aug 06, 2026. The company reported €0 earnings per share for the quarter, missing the consensus estimate of €0.02 by -€0.02.
          Is CareCloud overvalued?
          According to Wall Street analysts CareCloud’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does CareCloud pay dividends?
            CareCloud does not currently pay dividends.
            What is CareCloud’s EPS estimate?
            CareCloud’s EPS estimate is 0.08.
              How many shares outstanding does CareCloud have?
              CareCloud has 42,493,860 shares outstanding.
                What happened to CareCloud’s price movement after its last earnings report?
                CareCloud reported an EPS of €0 in its last earnings report, missing expectations of €0.02. Following the earnings report the stock price went down -2.713%.
                  Which hedge fund is a major shareholder of CareCloud?
                  Currently, no hedge funds are holding shares in DE:MTB0
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    CareCloud

                    CareCloud, Inc. operates as a specialized healthcare technology firm, delivering a comprehensive portfolio of cloud-powered solutions and related professional services. Its primary clientele consists of medical providers and hospitals throughout the United States. The company strategically organizes its activities into two core divisions: Healthcare IT and Medical Practice Management. Through its Software-as-a-Service (SaaS) platform, CareCloud provides essential tools for managing revenue cycles, administering practices, handling electronic health records, gleaning business insights, facilitating telehealth, and enhancing patient engagement. These offerings, complemented by various software utilities and tailored business services, are designed to empower diverse medical groups and health systems. Professionals such as doctors, nurses, physician assistants, and other clinical staff who render billable services are among its key users. Established in 1999 and based in Somerset, New Jersey, the entity was originally named MTBC, Inc. before officially adopting CareCloud, Inc. in March 2021.

                    CareCloud (MTB0) Earnings & Revenues

                    MTB0 Company Deck

                    MTB0 Earnings Call

                    Q2 2026
                    0:00 / 0:00
                    Earnings Call Sentiment|Positive
                    The call presents a constructive, strategic story: solid top-line growth (+16% Q2, +15% H1), a growing recurring revenue mix, continued GAAP profitability streak, a cleaner capital structure after fully redeeming Series B, and clear progress on AI and a new compliance SaaS initiative. Near-term reported profitability and some cash metrics are pressured by deliberate investment choices — accelerated R&D expense, acquisition-related amortization, and higher interest — and by integration work (notably Medsphere). Management reaffirmed guidance and expects a stronger second half as investments convert to scale. Overall, positives (revenue/regional trends, recurring revenue expansion, capital structure improvement, AI/product milestones, new market entry) outweigh the near-term headwinds driven by strategic investments and integration costs, but execution risk remains.View all DE:MTB0 earnings summaries

                    MTB0 Stock 12 Month Forecast

                    Average Price Target

                    €4.52
                    ▲(133.03% Upside)
                    {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"€0","7":"€7","1.75":"€1.75","3.5":"€3.5","5.25":"€5.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":6.88888488,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€6.89</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.5208307025,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€4.52</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.152776525,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€2.15</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,1.75,3.5,5.25,7],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.902,2.285606529230769,2.6692130584615383,3.0528195876923077,3.4364261169230765,3.8200326461538463,4.203639175384615,4.587245704615384,4.970852233846154,5.354458763076923,5.7380652923076925,6.121671821538461,6.50527835076923,{"y":6.88888488,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.902,2.103448515576923,2.304897031153846,2.506345546730769,2.707794062307692,2.909242577884615,3.110691093461538,3.312139609038461,3.513588124615384,3.715036640192307,3.91648515576923,4.117933671346154,4.319382186923076,{"y":4.5208307025,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.902,1.9212905019230768,1.9405810038461537,1.9598715057692306,1.9791620076923078,1.9984525096153847,2.0177430115384616,2.0370335134615387,2.0563240153846154,2.0756145173076925,2.094905019230769,2.1141955211538463,2.133486023076923,{"y":2.152776525,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.3,"date":1756674000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.67,"date":1759266000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.53,"date":1761948000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.59,"date":1764540000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.495,"date":1767218400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.205,"date":1769896800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2,"date":1772316000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.04,"date":1774990800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.406,"date":1777582800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.894,"date":1780261200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.727,"date":1782853200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.98,"date":1785531600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.902,"date":1788210000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Evolent Health
                    Phreesia
                    Health Catalyst
                    American Well
                    Waystar Holding Corp.
                    Popular Stocks